Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis

This guide covers: What insulin resistance actually is and why it matters The specific mechanisms through which semaglutide improves insulin sensitivity What clinical research shows about metabolic improvements Timeline for seeing results in lab values and symptoms How improvements relate to weight loss Comparing semaglutide to metformin and other treatments Who benefits most from semaglutide for insulin resistance Monitoring your progress and understanding your lab results Long-term implications for metabolic health Key Takeaways Semaglutide improves insulin resistance through multiple mechanisms , including direct effects on glucose metabolism and indirect effects through weight loss Improvements begin within weeks , with measurable changes in fasting glucose often appearing before significant weight loss Clinical trials show significant reductions in HbA1c (1.0-1.6 percentage points on average), fasting glucose, and fasting insulin levels Weight loss amplifies metabolic benefits , with each 5% of body weight lost producing meaningful additional improvement in insulin sensitivity Effects extend beyond blood sugar , improving blood pressure, cholesterol, liver fat, and inflammatory markers Many patients reduce or eliminate diabetes medications , including some who discontinue insulin entirely Semaglutide generally produces greater metabolic improvement than metformin , particularly for weight loss, though both medications have roles Prediabetes often reverses , with many patients returning to normal glucose tolerance Benefits require ongoing treatment , as insulin resistance typically worsens again if medication is stopped and weight regains Compounded semaglutide produces equivalent metabolic effects at lower cost ($199/month through TrimRx) Understanding Insulin Resistance Before exploring how semaglutide helps, understanding what insulin resistance actually is provides essential context

Research supports this cognitive connection
The dose is too low to produce significant weight loss or appetite suppression in most people